Evidence map›Paper›PMID 42763547›Full record

ReviewOsteoarthritis and cartilage open2026

Patient and healthcare professional perceptions of weight reduction in the treatment of knee osteoarthritis: A systematic literature review.

Philip G Conaghan, Catherine Rolland, James Frampton, Louis Lavoie, Katie Giblin, Rebecca Robinson, Magaly Perez-Nieves

Abstract readReview
In one paragraph

Review in Osteoarthritis and cartilage open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Philip G ConaghanLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Biomedical Research Centre, Leeds, United Kingdom.
Catherine RollandEvidera, a Thermo Fisher Scientific Company, London, United Kingdom.
James FramptonEvidera, a Thermo Fisher Scientific Company, London, United Kingdom.
Louis LavoieEvidera, a Thermo Fisher Scientific Company, Montreal, Canada.
Katie GiblinEli Lilly and Company, Indianapolis, IN, 46285, USA.
Rebecca RobinsonEli Lilly and Company, Indianapolis, IN, 46285, USA.
Magaly Perez-NievesEli Lilly and Company, Indianapolis, IN, 46285, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Weight reduction confers significant clinical benefits in knee osteoarthritis (OA) management. This systematic review examined patients' and healthcare professionals' (HCPs) perceptions of weight reduction for surgical, pharmacological and non-pharmacological interventions, with emphasis on barriers to implementation. Method: The review was conducted across Embase, MEDLINE, Cochrane, and PsycInfo for eligible studies using the Population, Intervention, Comparator, Outcome, Timeframe, and Study type framework. Results: The search identified 2134 publications; of these, 203 had full-text screening, with 46 studies included: 23 qualitative studies, 15 cross-sectional studies, 6 randomized-controlled trials, one quasi-experimental and one observational cohort study. Four main themes of barriers to weight reduction were identified, including limited knowledge, lack of access to interventions, OA-specific barriers to exercise, and non-OA-specific barriers to dieting and exercise. The patient-reported barriers included intrapersonal barriers (i.e., difficulty achieving weight reduction, lack of motivation), physical barriers (i.e., age, challenges with general movement), and social barriers (i.e., lack of social support). The HCP-reported barriers included knowledge barriers, communication barriers, and systemic barriers (i.e., time constraints and resource limitations). Both patients and HCPs had varying expectations and satisfaction levels regarding the impact and delivery of weight reduction interventions Conclusions: Despite broad recognition of weight reduction's benefits in knee OA, substantial barriers hinder adherence and implementation. Targeted strategies addressing patient-HCP communication, alongside enhanced education and training for both groups, are critical to improving weight reduction outcomes in this population. There is currently a gap in evidence around barriers to gastric surgery and pharmacological treatment specific to patients with knee OA.

Indexed as

Healthcare professionalsKnee osteoarthritisPatient perspectiveSystematic literature reviewWeight reduction

Identifiers

PMID42763547
PMCPMC13589083

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.